© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Early studies on nitric oxide changed the way many scientists looked at blood vessels and heart health. Years ago, researchers stumbled onto molecules that could change the course of medical science. Nω-Nitro-L-arginine Methyl Ester Hydrochloride, usually shortened to L-NAME, became a favorite tool in the labs. People often used it to block an enzyme that makes nitric oxide, opening doors to research on blood pressure, nerve signals, and inflammation. With the discovery of nitric oxide as a signaling molecule, curiosity about this compound soared. Today, it holds a permanent spot in cardiovascular and neurobiology labs around the world.
L-NAME doesn’t show up in daily conversation, but anyone working with animal models for hypertension or stroke knows it well. It works by slowing down the production of nitric oxide, which directly affects how blood vessels relax. Unlike more generic chemicals that show up in high school chemistry, this one delivers real, measurable change across biology experiments. Its reputation comes from years of meticulous testing, peer-reviewed studies, and the way it keeps surprising researchers by popping up in new applications.
L-NAME looks like a plain white powder to the naked eye. It dissolves easily in water-based solutions, which helps researchers get fast, repeatable results. With its well-documented melting point and reliable solubility, the compound slots neatly into both simple bench experiments and complex animal studies. Anyone working with it notices that storage matters—moisture and heat can ruin a batch, making it less effective or even unsafe. Even old-timers in the lab keep their bottles tightly sealed and stored away from light.
Labs that use L-NAME follow technical standards that aren’t just about purity or grade. Labels must state content by weight and percentage; batch numbers tell the story in case someone needs to track down a source of error. Documentation covers hazard codes, handling instructions, and expiration dates to remind users of both chemical and regulatory risks. This chemical asks for respect, and labeling reflects that. For someone new in the lab, the stack of paperwork can feel daunting, yet later on, it all makes sense—one slip-up with labeling can ruin months of research or worse, harm someone.
The preparation of L-NAME brings together more than one classic synthesis route. Arginine stands as a starting point, altered by nitrosation and methylation. Each step needs steady hands and careful control of temperature and reaction timing. The hydrochloride salt comes in at the final stage, making the compound more stable and easier to handle. Every supply company boasts a slightly different process, tuned over years for yield and cleanliness, but the core steps remain consistent. Problems during synthesis can throw off purity, so trusted manufacturers run extra checks before bottling anything up.
L-NAME stays pretty stable, but its main trick is blocking nitric oxide synthase. That’s why it draws so much attention in cardiovascular research and immune system studies. The methyl ester part makes it easier to work with than its parent compound, L-NG-Nitroarginine. If researchers want to tweak its function, they sometimes swap groups at the terminal end or change the salt, hoping for altered absorption or slower breakdown in tissues. Some groups have also made fluorescent versions that help to track activity inside living cells—pulling back the curtain even further on cellular mechanisms tied to nitric oxide.
Long chemical names don’t roll off the tongue, so most people choose “L-NAME” in conversation. The formal label reads as Nω-Nitro-L-arginine methyl ester hydrochloride, and older texts might mention “nitroarginine methyl ester” or just “L-Nitroarginine.” Whichever name shows up, the structure and the science stay the same—no one working in the field confuses it with other arginine derivatives.
Working with L-NAME means following safety routines without shortcuts. Researchers wear gloves and goggles, no matter how familiar they get. Inhalation, skin contact, or accidental ingestion require immediate first aid measures for a reason—lab accidents aren’t just scary, they can stop research and threaten health. Most reputable institutions push for clear protocols: chemical fume hoods, spill-kits, waste tracking, and regular training refreshers. Safety data sheets stay within arm’s reach, and experienced supervisors keep an eye out for bad habits that sneak in over time. Complying with these standards isn’t bureaucracy—it protects people so the science can move forward.
L-NAME made its name in blood pressure research, but it rarely stops there. It gets picked for projects tackling heart attack risk, early atherosclerosis, and even memory changes after brain injury. Once, I watched a team test L-NAME in mouse models for kidney damage linked to diabetes. Their results hinted at linkages between nitric oxide and inflammation that would have gone unnoticed with broader inhibitors. Pain studies sometimes include L-NAME to tease apart the role of nitric oxide in nerve signaling. Pharmaceutical companies explore its potential as a lead compound, trying small structure tweaks to find something safer or more specific. Far from a one-trick pony, this chemical keeps finding purpose across disciplines.
Research groups approach L-NAME from every angle—molecular biology, pharmacology, toxicology, and even computational modeling. The last decade brought a wave of research on nitric oxide as both a friend and foe in heart disease and cancer. At several conferences, I saw lively debates over the timing and dosing of L-NAME in preclinical models. More teams now look at the interplay between L-NAME and other metabolic pathways. Others dig into how long-term use changes vascular health, or test combinations with anti-inflammatory drugs. Journals publish dozens of papers each year showing both the promise and the sticking points. At the center remains a molecule with more potential than most would guess at first sight.
No chemical used in living systems comes without risks. L-NAME’s ability to block nitric oxide synthase means it can throw off more than just blood pressure. Extended use in animal models leads to kidney problems, arterial stiffness, and sometimes impaired learning. Toxicology labs take note when doses get high, watching for subtle changes in behavior or tissue structure that could explain unexpected results. Monitoring for off-target effects turns into a full-time job in longer studies. These findings highlight the importance of strong experimental controls—not just for accuracy, but for ethics.
L-NAME set a gold standard for enzyme inhibition in cardiovascular research, but the search for something even better never stops. Future projects look poised to focus on specificity—engineering molecules that turn off only one flavor of nitric oxide synthase, or that work in select tissues. People talk about improved drug delivery, where L-NAME analogues target diseased areas with fewer side effects. Some research labs work to combine L-NAME with imaging agents, creating hybrids that can both diagnose and alter disease at the same time. As our understanding of nitric oxide signaling deepens, so does the list of applications. With advances in genetic engineering, more groups will use L-NAME in knock-in or knock-out models, dialing in on pathways that used to be black boxes. It’s hard not to feel curious about where all this will lead—L-NAME’s history suggests there’s much more to learn from this simple yet powerful molecule.
Nω-Nitro-L-arginine Methyl Ester Hydrochloride—often called L-NAME in research circles—sounds like a mouthful. Yet, this compound’s not rare in scientific labs. Years ago, slipping into my first proper lab coat, I learned how biochemists focus on the small stuff to tackle big health problems. One of those “small things” is nitric oxide in our bodies. A naturally produced gas, nitric oxide impacts blood vessels, brain signals, and immunity. L-NAME enters the conversation because it blocks the production of this gas, giving scientists a way to study what happens when the flow slows down or halts.
Medical research leans heavily on animal models to predict human health. In studies about blood pressure, L-NAME stands nearly as a household name among scientists. Giving lab animals L-NAME helps create high blood pressure, or hypertension, on cue. That’s how researchers get a safe and controlled way to test what might bring blood pressure back down. Without that tool, new medications and treatments would face a much rougher ride to clinical trials.
Beyond blood pressure, nitric oxide’s presence stretches across disease lines. From stroke to Alzheimer’s, its absence or overproduction links up with real health consequences. L-NAME lets scientists investigate every angle, acting like a switch that turns nitric oxide creation off. Watching the changes in animal models gives researchers clues about what nitric oxide does and how drugs might protect or repair tissues. I remember working with neurologists who leaned on L-NAME for early tests in brain-injury studies, always hoping to better predict what works before bringing ideas to human trials.
University labs and pharmaceutical companies must follow strict safety standards with L-NAME. The compound’s power to shift blood pressure makes it risky if handled carelessly. Even a brief encounter with concentrated powders or solutions can pose health hazards, so teams always gear up with gloves, goggles, and ventilation. Procedures get reviewed constantly; mistakes, if any, lead to thorough internal investigations. Since nitric oxide pathways tie in with so many body systems, unwanted side effects sometimes crop up in experiments—another reminder why the compound belongs in skilled hands.
L-NAME isn’t a medicine people pick up at pharmacies. Instead, it’s a workhorse for medical progress. By allowing scientists to shut down a key pathway, it helps simulate health problems thousands of people face day after day—heart failures, strokes, circulatory malfunctions. The knowledge gained from L-NAME-driven studies ripples out to shape the drugs doctors might see in hospitals years later.
Some scientists now push for digital modeling to take over animal studies, raising questions about how long L-NAME will play such a central role. For now, few substitutes offer the same level of control—or the same glimpse into what makes diseases tick. It reminds me that behind every medical breakthrough lies a string of tiny steps, and sometimes, a chemical like L-NAME ends up pushing progress further than any one treatment or tech ever could.
Walking into the lab early with a fresh batch of Nω-Nitro-L-arginine Methyl Ester Hydrochloride (often called L-NAME), the attention turns quickly to safety and long-term stability. This compound doesn’t tolerate sloppy storage, which anyone dealing with research-grade reagents will agree. During my own years in the lab, I learned the hard way that a chemical’s performance often tracks directly with handling and storage habits.
L-NAME absorbs water from the air like a thirsty sponge. Let a cap sit ajar, and you can almost feel it pulling in moisture, especially in older labs where humidity creeps up despite efforts. From published data and supplier recommendations, it’s clear that degradation picks up if this compound isn’t kept dry and in cool conditions. High humidity and temperature changes cause clumping, color shifts, and even reduced biological activity in experimental setups. This isn’t theory—it’s reality for anyone who’s run a handful of nitric oxide inhibition experiments and seen the control readings drift unexpectedly.
Start with an airtight container. Many use amber glass vials, which help block light—another enemy for many fine powdered reagents. After dosing out a working aliquot, sealing containers tightly and returning them to a desiccator saves plenty of grief. Desiccant packets—like the ones found inside vitamin bottles—are much more than an afterthought. They help mop up stray moisture and slow down hydrolysis.
Next comes refrigeration. A dedicated fridge for chemicals keeps Nω-Nitro-L-arginine Methyl Ester Hydrochloride at a stable 2-8°C. Ordinary fridges packed with lunches and water bottles just don’t have the same temperature stability, and frequent door opening impacts humidity. Some labs, especially those with larger budgets, install fridge alarms to keep tabs on temperature swings—one less thing to worry about during a blackout.
Mislabeled or poorly tracked compounds increase the risk of accidental misuse. Each container needs a clear label showing arrival date, supplier, and date opened. It’s helpful to mark whether the batch has ever been removed from cold storage (to reduce unnecessary freeze-thaw cycles). Every time someone pulls a vial, there’s potential for exposure to warm, humid air. Dividing larger stocks into smaller, single-use aliquots helps a lot here. Instead of thawing and refreezing a big bottle over and over, one can grab a single aliquot, finish the work, and never expose the rest of the batch.
From personal experience and conversation with colleagues, cross-contamination emerges as another hidden risk. Powder clings to tools, glass, even gloves. Dedicated scoops and careful technique matter. Spills, no matter how minor, can downgrade purity and waste money—particularly since good L-NAME isn’t cheap.
In the race to set up an experiment, the urge to cut corners grows. Still, a little discipline at the storage shelf brings more consistent results. Nobody wants to chase unexplained variability in their nitric oxide assays or figure out why a key batch just “doesn’t work” anymore.
Sound storage of Nω-Nitro-L-arginine Methyl Ester Hydrochloride is more than just following instructions. It protects health, budgets, and research outcomes. Small changes in how containers get handled, where they rest, and the willingness to slow down and label every bottle make measurable differences. For most labs, putting in that extra care pays off in reliability and reproducibility—qualities every scientist values, and every study demands.
Anyone stepping into pharmacology or vascular research will probably come across Nω-Nitro-L-arginine methyl ester hydrochloride, or L-NAME for short. This nitric oxide synthase inhibitor has become a staple in labs for its clear, replicable effect on nitric oxide pathways. Picking the correct dosage isn’t a minor question—it shapes study outcomes and reproducibility across different groups working in the same field.
Most published research points to a range of 10 to 50 mg per kg body weight per day for animal experiments, especially rodents. Intraperitoneal injection or administration in drinking water are two main routes. The dosing often depends on the purpose of the study. Low doses such as 10 mg/kg may show subtle changes in vascular tone, and higher doses (up to 50 mg/kg) can induce noticeable changes in blood pressure or tissue blood flow. I’ve looked through studies where 25 mg/kg a day became the go-to when long-term inhibition was the goal.
Mismatch in dosage can lead to very different results. If the dose drops too low, the desired inhibition of nitric oxide synthesis might not show up at all. Push it too high, and it can turn toxic, leading to confounding effects like weight loss, organ damage, or even lethality. In my own lab experience, using a middle-ground dose reduced such risks while still triggering measurable physiological changes.
Some scientists use L-NAME for acute experiments and others for chronic models. Acute models, such as a single IP injection, often sit at 20-30 mg/kg. Chronic studies sometimes use 50 mg/L dissolved in drinking water. Calculating the average water consumption of the animals in each cage helps estimate the dose per kg per day. Over years in the lab, I’ve learned exact numbers should always come from both literature and pilot studies because rat strains or experimental protocols can skew the dose-response relationship.
The Nobel Prize-winning discovery of nitric oxide's role in the cardiovascular system raised the stakes. Since then, an explosion of papers standardized the dosing, but reporting sometimes falls short. Recent reviews urge researchers to specify both the concentration and method of administration. I’ve seen firsthand how transparency in methods speeds up progress and prevents wasted effort or flawed replication.
Reading through protocols in top journals, checking supplier recommendations, and running a quick pilot assay often settle the debate before full-scale study begins. Including toxicity markers and body weight measurements lets you spot alarming side effects quickly. Good record-keeping gives teams room for honest troubleshooting.
Nω-Nitro-L-arginine methyl ester hydrochloride shapes experiments aimed at understanding cardiovascular or neurovascular physiology. Typical doses sit between 10 to 50 mg/kg for rodents, delivered acutely or through drinking water. Accuracy, transparency, and awareness of animal welfare turn a confusing question into a tool for stronger, more meaningful results.
Sitting across a benchtop covered with lab glassware, I once worried about splashing solvents, dropping heavy flasks, or breaking a thermometer. Yet, something about small white powders—especially ones with long, technical names—raises the level of caution. Nω-Nitro-L-arginine Methyl Ester Hydrochloride, though sounding like a harmless academic mouthful, deserves careful handling. This compound, popular in nitric oxide research, carries real dangers if ignored.
Splitting open a chemical’s packaging, the fine dust sometimes escapes. Eyes start to water, throat itches, and panic hits. Chemicals like this are no joke—even if not famously toxic, they bring their own risks. Dermal exposure often sparks irritation or allergic reactions. Simple gloves seem obvious, yet I’ve seen rushed colleagues skip them, later regretting it with an itchy, red patch. Protective clothing should cover arms, and good lab hygiene—hand washing, no face touching—makes a difference here.
Powders can float. Nω-Nitro-L-arginine Methyl Ester Hydrochloride shouldn’t become airborne. Respiratory protection, like a reliable mask, helps if weighing out the compound. Fume hoods work better for weighing and transferring, giving an added layer between your lungs and whatever’s in the air. In small academic settings, undergraduates sometimes forget this step—tight schedules and busy labs nudge them toward shortcuts. It only takes one accidental sneeze to shake you out of bad habits.
This compound absorbs moisture from the air, transforming into sticky clumps if left exposed. Sealing containers helps, along with labeling and storing away from incompatible materials. One evening, I fumbled a bottle, and only a well-prepped spill kit kept things under control. Absorbent pads, gloves, and grab-and-go containers paid for themselves, preventing messes that could become emergencies.
Even with all precautions, things go wrong. Eyewash stations and showers in reach spare time, but they’re useless if blocked by clutter. Quick response is everything for splashes or inhalation cases. Having numbers for poison control visible helps, as does knowing nearby trained help. I’ve seen postdocs freeze in shock, wasting precious minutes, so routine drills and clear instructions become just as vital as wearing safety goggles.
Too much information can overwhelm, but too little puts people at risk. The best labs post visible safety sheets covering known risks and have supervisors who actually talk through hazards with junior team members. Stories from older colleagues stick better than printed warnings—for example, tales of a leaking glove turning into a three-day rash. Open conversation helps build a safety-first culture where watching out for one another beats relying on luck.
So, what keeps people safe with Nω-Nitro-L-arginine Methyl Ester Hydrochloride? Direct, consistent use of gloves and eye protection. Masks and hoods for any open handling. Spill kits and organized storage. Accessible emergency equipment. Guidelines shared in real language. Each measure protects against surprises, mistakes, and forgetfulness. Sometimes safety becomes rote, but those habits mean everyone gets through another day in the lab without regrets.
Nitric oxide serves as an essential messenger in our bodies, playing its part in blood vessel health, nerve signaling, and immune defense. Nω-Nitro-L-arginine methyl ester hydrochloride, often called L-NAME, earns its reputation in research labs by putting the brakes on nitric oxide synthase (NOS), the enzyme responsible for nitric oxide production. Grasping how L-NAME works opens a door to more targeted therapies and a deeper understanding of blood pressure, inflammation, and even memory.
L-NAME steps into the picture as a chemical cousin of L-arginine, the amino acid NOS usually transforms into nitric oxide. Since NOS sees L-NAME and L-arginine as twins, the enzyme grabs L-NAME when it appears, slowing down the enzyme's work. Instead of generating nitric oxide, the enzyme stalls. At the molecular level, L-NAME binds tightly to the active site of NOS, preventing real L-arginine from attaching. As production of nitric oxide drops, blood vessels constrict and signaling shifts. For folks studying hypertension or immune reactions, this offers a practical way to test what happens when nitric oxide goes missing.
Lab scientists learned a lot from L-NAME's stubborn blocking effect. It helped demonstrate how nitric oxide keeps blood pressure steady. In studies where L-NAME is given to animals, researchers saw spikes in blood pressure and learned which organs depend on steady nitric oxide. Those insights have shaped the direction of cardiovascular research. Personally, seeing older relatives with high blood pressure and hearing about the risks of stroke drove home the importance of these discoveries. Pinpointing how enzymes work behind the scenes provides hope for designing new drugs or balancing side effects from ones already in use.
L-NAME plays a role in understanding more than just heart health. For people facing chronic inflammation or autoimmune problems, nitric oxide becomes a double-edged sword. It can defend the body, but too much can fuel tissue damage. L-NAME allows researchers to slow nitric oxide production and study how inflammatory diseases change as a result. That’s useful for exploring new treatments for conditions like arthritis, sepsis, or even neurodegeneration. Recent studies link the overproduction of nitric oxide to nerve cell loss, bringing fresh ideas for addressing conditions like Alzheimer’s or Parkinson’s.
The interaction between L-NAME and NOS highlights how small molecules can block large biological processes. Targeted drugs inspired by L-NAME could soon come with fewer side effects or more control over where nitric oxide gets shut down. For example, new compounds are in the works, focusing their action in the brain or blood vessels but sparing the rest of the body. Applying what is learned from L-NAME also means thinking about how to restore balance, maybe with diet—since L-arginine is found in nuts, seeds, and lean meats—or exercise, which boosts nitric oxide levels naturally. Improved screening for nitric oxide function might flag early signs of heart disease or immune troubles, long before major symptoms show up.
| Names | |
| Preferred IUPAC name | methyl (2S)-2-amino-5-[(Nω-nitro-L-arginino)amino]pentanoate hydrochloride |
| Other names |
L-NAME N(G)-Nitro-L-arginine methyl ester hydrochloride Nω-Nitro-L-arginine methyl ester hydrochloride N(omega)-Nitro-L-arginine methyl ester hydrochloride |
| Pronunciation | /ɛn-ˈnɪtroʊ-ɛl-ɑːrˈdʒɪniːn ˈmɛθɪl ˈɛstər haɪˌdrɒklaɪd/ |
| Identifiers | |
| CAS Number | 51298-62-5 |
| Beilstein Reference | 60378 |
| ChEBI | CHEBI:7546 |
| ChEMBL | CHEMBL19353 |
| ChemSpider | 2275464 |
| DrugBank | DB08344 |
| ECHA InfoCard | 100.134.136 |
| EC Number | 2.5.1.10 |
| Gmelin Reference | 82776 |
| KEGG | C14826 |
| MeSH | D015928 |
| PubChem CID | 439246 |
| RTECS number | SG3150000 |
| UNII | PL3636MUD8 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C7H16N4O4·HCl |
| Molar mass | 324.8 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Solubility in water | Soluble in water |
| log P | -2.7 |
| Acidity (pKa) | 13.2 |
| Basicity (pKb) | 11.08 |
| Magnetic susceptibility (χ) | -13.6 × 10⁻⁶ cm³/mol |
| Viscosity | Viscous oil |
| Dipole moment | 3.15 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 313.7 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | C01DX11 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P261, P271, P280, P304+P340, P312, P405, P501 |
| Lethal dose or concentration | LD50 Oral Mouse 2260 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse intravenous 55 mg/kg |
| NIOSH | 98-07-7 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 50-200 μM |
| Related compounds | |
| Related compounds |
L-Arginine Nω-Nitro-L-arginine L-NAME NG-Monomethyl-L-arginine Nω-Nitro-D-arginine methyl ester |
